Status:
COMPLETED
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Lead Sponsor:
Laboratoires Thea
Conditions:
Eyelid Diseases
Eligibility:
All Genders
4+ years
Phase:
PHASE4
Brief Summary
Multicentric study, open label, uncontrolled phase IV in 140 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocu...
Eligibility Criteria
Inclusion
- Signed and dated informed consent.
- Male or female up to 4 years old.
- Known and treated symptomatic Meibomian Gland Diseases, and/or Dry Eye related to MGDs stable since at least a month.
- Without any active pathology requiring a change in ocular treatments within the last month before inclusion.
- Best corrected far visual acuity (VA) \> 1/10
Exclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT01189474
Start Date
June 1 2010
End Date
December 1 2011
Last Update
October 3 2012
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU d'Amiens
Amiens, France, 80054
2
Hopital Pellegrin
Bordeaux, France, 33000
3
CHU de Dijon
Dijon, France, 21000
4
76 Allée des Pins Tranquilles
Hossegord, France, 40150